Unpack ACC.24's Top Trials with View from the Thoraxcenter! Join Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC, Rotterdam for a deep dive into the late-breaking data presented at ACC.24. In this thought-provoking ACC 2024 wrap-up, delve into the nuances of the most impactful trials, gaining insights into their implications for current practice and future research directions. 00:29 - Ultimate DAPT 02:49 - IVUS-ACS 04:22 - RELIEVE-HF 08:00 - ORBITA-COSMIC 11:12 - EMPACT-MI 14:36 - REDUCE-AMI 17:51 - DEDICATE-DZHK6 22:32 - SMART 26:26 - PREVENT 29:08 - FULL REVASC 33:43 - DanGer Sh ..read more

In this episode of the Radcliffe Podcast, we are joined by Dr Raymond Pranata, Dr Mohammad Iqbal and Dr Giky Karwiky (Hasan Sadikin General Hospital, Bandung, Indonesia) as they discuss their recently published systematic review and meta-analysis of very-high-power short-duration ablation as compared to conventional ablation for the treatment of pulmonary vein isolation in atrial fibrillation. 13 studies were included in their analysis, which found that VHPSD ablation was associated with lower AF recurrence as compared to the conventional ablation group. Subgroup analysis showed that additiona ..read more

What's hot at #AHA23? Join Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) as they review the latest late-breaking science data from AHA Scientific Sessions 2023. They interpret the evidence from five key trials, providing context, asking thought-provoking questions to translate the data into key take-home messages for practice and research. Trials Covered include: 00:20 - DAPA-MI: Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack 06:30 - ORBITA-2: Percutaneous Coronary Intervention for Stable Angina: A Randomised, P ..read more

What are the top late-breaking trials from #TCT2023? TCT 2023 — Join interventional cardiologists, Prof Nicolas Van Mieghem and Dr Joost Daemen from the Thoraxcenter as they unpack the most impactful late-breaking clinical trials and science data from this year's Transcatheter Cardiovascular Therapeutics Conference. Dive into this practical and engaging discussion and learn more about the latest data for practice and for research. We value your opinion! Share your feedback by commenting on this page or sending us an email at info@radcliffe-group.com. Trials covered: 00:20 - PARTNER 3 Low-Risk ..read more

What are the take-home messages from ESC 2O23? Join us as we delve into the pivotal results that ignited debates and discussions at ESC Congress 2023. Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) return with their "View from the Thoraxcenter" review, where they analyse the hot line and late-breaking trials presented in Amsterdam. In this ESC 2023 wrap-up, Prof Van Mieghem and Dr Daemen will dissect the data, evaluating real-world applicability, and distilling findings into actionable insights for clinical practice ..read more

In this episode of the Radcliffe Podcast, we are joined by Dr Mirvat Alasnag (King Fahd Armed Forces Hospital, SA), Dr Khalid AlJohani (King Saud University, SA), and Dr Abdulrahman AlMoghairi (Prince Sultan Cardiac Center, SA) as they discuss methods and approaches to left main percutaneous coronary revascularization. In this podcast, Dr Alasnag, Dr AlJohani and Dr AlMoghairi discuss the current guidelines for left main PCI, the techniques they use to position and optimise left main ostial stents, and intracoronary imaging to assist stent placement in the left main artery. They also discuss r ..read more

Join Masterclass host, Dr. Harriette Van Spall (McMaster University, CA), in an in-depth interview with Dr. Clyde W. Yancy (Northwestern University, US). Dr. Yancy, an internationally respected leader and mentor in cardiology, holds positions as the Vice Dean of Diversity and Inclusion, Magerstadt Professor of Medicine, and Chief of the Division of Cardiology at Northwestern University's Feinberg School of Medicine. He is also the Associate Director at the Bluhm Cardiovascular Institute Northwestern Memorial Hospital and a Deputy Editor of JAMA Cardiology. Discover Dr. Clyde W. Yancy's extraor ..read more

In this episode from the Radcliffe Podcast, Dr Francisco Jiminez-Lopez (Mayo Clinic, US) and Dr David Harmon (Mayo Clinic, US) join us to discuss the future of AI in Atrial Fibrillation treatment, based on Dr Harmon's recently published article in AER Journal; 'Artificial intelligence for the detection and treatment of atrial fibrillation'. Dr Jiminez-Lopez and Dr Harmon discuss the possibilities that recent advances in the detection of atrial fibrillation using artificial intelligence-based technology offer, discussing its place in practice with consideration to standard practice electrocardi ..read more

In this episode of the Radcliffe Cardiology Podcast, we are joined by Dr Jack Tan (National Heart Centre, SG) and Dr Chris Plummer (The Newcastle upon Tyne Hospitals NHS Foundation Trust, UK), who provide an overview of a recent JAPSC Journal article based on the European Examination in Core Cardiology. The test aims to provide a broad and balanced evaluation of the key knowledge required by cardiology speciality trainees. Dr Plummer outlines the main components of the test, as well as the methods used to determine the questions used within the examination. Prefer to watch in video format? Cli ..read more

In this episode of "View from the Thoraxcenter," Prof Nicolas Van Mieghem and Dr Joost Daemen preview the most anticipated late-breaking and featured science trials of ACC.23 and discuss their potential impact on patient care and research. The trials covered include structural interventions such as TRILUMINATE Pivotal, UK Mini Mitral, COAPT, and Evolut Low Risk, as well as coronary interventions including REVIVED-BCIS2, RENOVATE-COMPLEX-PCI, and BIOVASC. Additionally, they cover trials related to statins, including Yellow III, CLEAR Outcomes, and MK-0616. Tune in for the latest developments in ..read more